Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity
Authors:
- 1 November 1992
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 66 (11) , 6616-25
Abstract
Human immunodeficiency virus type 1 contains a transmembrane glycoprotein with an unusually long cytoplasmic domain. To determine the role of this domain in virus replication, a series of single nucleotide changes that result in the insertion of premature termination codons throughout the cytoplasmic domain has been constructed. These mutations delete from 6 to 192 amino acids from the carboxy terminus of gp41 and do not affect the amino acid sequence of the regulatory proteins encoded by rev and tat. The effects of these mutations on glycoprotein biosynthesis and function as well as on virus infectivity have been examined in the context of a glycoprotein expression vector and the viral genome. All of the mutant glycoproteins were synthesized, processed, and transported to the cell surface in a manner similar to that of the wild-type glycoprotein. With the exception of mutants that remove the membrane anchor domain, all of the mutant glycoproteins retained the ability to cause fusion of CD4-bearing cells. However, deletion of more than 19 amino acids from the C terminus of gp41 blocked the ability of mutant virions to infect cells. This defect in virus infectivity appeared to be due at least in part to a failure of the virus to efficiently incorporate the truncated glycoprotein. Similar data were obtained for mutations in two different env genes and two different target cell lines. These results indicate that the cytoplasmic domain of gp41 plays a critical role during virus assembly and entry in the life cycle of human immunodeficiency virus type 1.Keywords
This publication has 35 references indexed in Scilit:
- Shorter size of transmembrane glycoprotein of an HIV-1 isolateAIDS, 1990
- Expanded HIV-1 Cellular Tropism by Phenotypic Mixing with Murine Endogenous RetrovirusesScience, 1990
- SIV adaption to human cellsNature, 1989
- Role of the Carboxy-Terminal Portion of the HIV-1 Transmembrane Protein in Viral Transmission and CytopathogenicityAIDS Research and Human Retroviruses, 1989
- Theoretically Determined Three-Dimensional Structures for Amphipathic Segments of the HIV-1 gp41 Envelope ProteinAIDS Research and Human Retroviruses, 1989
- A charged amino acid substitution within the transmembrane anchor of the Rous sarcoma virus envelope glycoprotein affects surface expression but not intracellular transport.Journal of Cell Biology, 1987
- The genome organization of STLV-3 is similar to that of the AIDS virus except for a truncated transmembrane proteinCell, 1987
- The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brainCell, 1986
- Binding of HTLV-III/LAV to T4 + T Cells by a Complex of the 110K Viral Protein and the T4 MoleculeScience, 1986
- Rous sarcoma virus p19 and gp35 can be chemically crosslinked to high molecular weight complexesJournal of Molecular Biology, 1984